Cargando…
miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma
Dysregulation of miRNAs is involved in osteosarcoma (OS). Here, we demonstrate that miR-382 is decreased in specimens of OS patients with a poor chemoresponse compared to those with a good chemoresponse. In addition, our clinical data show that decreased miR-382 was associated with poor survival in...
Autores principales: | Xu, Meng, Jin, Hua, Xu, Cheng-Xiong, Sun, Bo, Mao, Zhi, Bi, Wen-Zhi, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253447/ https://www.ncbi.nlm.nih.gov/pubmed/25344865 |
Ejemplares similares
-
MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer
por: Yao, Hui, et al.
Publicado: (2019) -
Blocked Autophagy by miR-101 Enhances Osteosarcoma Cell Chemosensitivity In Vitro
por: Chang, Zhiqiang, et al.
Publicado: (2014) -
MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2
por: Liu, Yang, et al.
Publicado: (2017) -
Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma
por: Li, Yunchao, et al.
Publicado: (2016) -
LINC00265 targets miR-382-5p to regulate SAT1, VAV3 and angiogenesis in osteosarcoma
por: Xiao, Ying, et al.
Publicado: (2020)